We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+23.56%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$135M
AUM Growth
+$62.2M
Cap. Flow
+$48.4M
Cap. Flow %
35.91%
Top 10 Hldgs %
44.79%
Holding
162
New
9
Increased
113
Reduced
25
Closed
15

Top Buys

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$4.79M
2
EEP
Enbridge Energy Partners
EEP
+$3.1M
3
PAA icon
Plains All American Pipeline
PAA
+$2.86M
4
WPZ
Williams Partners L.P.
WPZ
+$2.84M
5
ETP
Energy Transfer Partners, L.P.
ETP
+$2.77M

Top Sells

Rank Stock Value
1
TRGP icon
Targa Resources
TRGP
+$572K
2
XNPT
XENOPORT, INC.
XNPT
+$458K
3
MDVN
MEDIVATION, INC.
MDVN
+$291K
4
TBPH icon
Theravance Biopharma
TBPH
+$289K
5
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$275K

Sector Composition

Rank Sector Weight
1 Energy 64.17%
2 Healthcare 25.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAGE
76
DELISTED
Sage Therapeutics
SAGE
$264K 0.2%
8,774
+4,172
+91% +$139K
VTAE
77
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$264K 0.2%
24,463
+6,933
+40% +$59.3K
MGNX icon
78
MacroGenics
MGNX
$255M
$263K 0.2%
9,762
+1,377
+16% +$31.1K
BLCM
79
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$263K 0.2%
2,030
+610
+43% +$67.9K
NERV icon
80
Minerva Neurosciences
NERV
$207M
$262K 0.19%
+3,204
New +$204K
CLDX icon
81
Celldex Therapeutics
CLDX
$2.78B
$261K 0.19%
3,969
+2,819
+245% +$179K
SGYP
82
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$259K 0.19%
68,254
+24,913
+57% +$84.4K
RDUS
83
DELISTED
Radius Health, Inc.
RDUS
$257K 0.19%
6,986
+2,900
+71% +$102K
AGEN
84
Agenus
AGEN
$258M
$256K 0.19%
3,220
-68
-2% -$5.3K
LXRX icon
85
Lexicon Pharmaceuticals
LXRX
$1.02B
$253K 0.19%
17,649
-1,618
-8% -$21.9K
DVAX
86
DELISTED
Dynavax Technologies
DVAX
$252K 0.19%
17,302
+7,534
+77% +$129K
ITCI
87
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$250K 0.19%
+6,443
New +$232K
ADXS
88
DELISTED
Advaxis Inc
ADXS
$250K 0.19%
2,059
-30
-1% -$3.84K
OMED
89
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$250K 0.19%
20,269
+7,900
+64% +$95.9K
ONC
90
BeOne Medicines Ltd
ONC
$33.9B
$249K 0.18%
+8,344
New +$245K
SRPT icon
91
Sarepta Therapeutics
SRPT
$1.68B
$247K 0.18%
12,949
+6,179
+91% +$114K
GERN icon
92
Geron
GERN
$930M
$246K 0.18%
91,851
+35,915
+64% +$105K
PTCT icon
93
PTC Therapeutics
PTCT
$6.51B
$245K 0.18%
34,849
+26,072
+297% +$191K
SIOX
94
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$245K 0.18%
2,383
+811
+52% +$81.1K
CLVS
95
DELISTED
Clovis Oncology, Inc.
CLVS
$245K 0.18%
17,865
+10,339
+137% +$151K
KYNB
96
Kyntra Bio
KYNB
$28.6M
$244K 0.18%
595
+266
+81% +$122K
KITE
97
DELISTED
Kite Pharma, Inc.
KITE
$244K 0.18%
4,889
+949
+24% +$46.6K
INSM icon
98
Insmed
INSM
$23.3B
$242K 0.18%
24,536
+9,748
+66% +$114K
NBIX icon
99
Neurocrine Biosciences
NBIX
$17.5B
$242K 0.18%
5,324
+564
+12% +$26K
TRVN
100
DELISTED
Trevena, Inc.
TRVN
$242K 0.18%
61
+23
+61% +$108K
2 3
4
5 6

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
OC
Optima Capital Beaverton, Oregon $215M AUM 17.28% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Virtus ETF Advisers's Q2 2016 Portfolio in Review

As of Q2 2016, Virtus ETF Advisers held 162 positions worth $135M, up 86% from $72.6M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Virtus ETF Advisers deployed $48.4M of net new capital in Q2 2016, opening 9 new positions and adding to 113 existing holdings. Its largest new stake was Cheniere Energy: 11,685 shares worth $350K.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 49% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Targa Resources, an estimated $572K trimmed.

  • Virtus ETF Advisers's largest Q2 2016 buy was Cheniere Energy: 11,685 shares worth $350K.
  • Virtus ETF Advisers added most to Energy Transfer Partners L.p. in Q2 2016, an estimated $4.79M increase.
  • Virtus ETF Advisers's biggest Q2 2016 reduction was Targa Resources, cutting an estimated $572K.
  • Virtus ETF Advisers fully exited XENOPORT, INC. in Q2 2016, selling an estimated $458K.
  • Virtus ETF Advisers's ten largest holdings make up 45% of its $135M portfolio in Q2 2016.
  • Virtus ETF Advisers opened 9 new positions and closed 15 in Q2 2016.
  • Virtus ETF Advisers's portfolio value rose 86% quarter-over-quarter to $135M.

Based on Virtus ETF Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.